American College of Rheumatology White Paper on Performance Outcome Measures in Rheumatology

被引:25
|
作者
Suter, Lisa G. [1 ,2 ,3 ]
Barber, Claire E. [4 ]
Herrin, Jeph [1 ,5 ]
Leong, Amye [6 ]
Losina, Elena [7 ]
Miller, Amy [8 ]
Newman, Eric [9 ]
Robbins, Mark [10 ]
Tory, Heather [11 ,12 ]
Yazdany, Jinoos [13 ]
机构
[1] Yale Sch Med, 300 Cedar St,Room TAC S541,POB 208031, New Haven, CT 06520 USA
[2] YNHHSC Ctr Outcome Res & Evaluat, New Haven, CT USA
[3] VA Connecticut Healthcare Syst, West Haven, CT USA
[4] Univ Calgary, Calgary, AB, Canada
[5] Hlth Res & Educ Trust, Chicago, IL USA
[6] Hlth Motivat & Bone & Joint Decade Global Allianc, Santa Barbara, CA USA
[7] Harvard Med Sch, Brigham & Womens Hosp, Orthoped & Arthrit Ctr Outcomes Res, Boston, MA USA
[8] Amer Coll Rheumatol, 60 Execut Pk S,Suite 150, Atlanta, GA 30329 USA
[9] Geisinger Hlth Syst, Danville, PA USA
[10] Harvard Vanguard Med Associates, Atrius Hlth, Somerville, MA USA
[11] Connecticut Childrens Med Ctr, Hartford, CT USA
[12] Univ Connecticut, Sch Med, Farmington, CT USA
[13] Univ Calif San Francisco, San Francisco, CA 94143 USA
基金
美国医疗保健研究与质量局;
关键词
HEALTH-ASSESSMENT QUESTIONNAIRE; QUALITY; INDICATORS; ARTHRITIS; MORTALITY; CARE;
D O I
10.1002/acr.22936
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To highlight the opportunities and challenges of developing and implementing performance outcome measures in rheumatology for accountability purposes. Methods. We constructed a hypothetical performance outcome measure to demonstrate the benefits and challenges of designing quality measures that assess patient outcomes. We defined the data source, measure cohort, reporting period, period at risk, measure outcome, outcome attribution, risk adjustment, reliability and validity, and reporting approach. We discussed outcome measure challenges specific to rheumatology and to fields where patients have predominantly chronic, complex, ambulatory care-sensitive conditions. Results. Our hypothetical outcome measure was a measure of rheumatoid arthritis disease activity intended for evaluating Accountable Care Organization performance. We summarized the components, benefits, challenges, and tradeoffs between feasibility and usability. We highlighted how different measure applications, such as for rapid cycle quality improvement efforts versus pay for performance programs, require different approaches to measure development and testing. We provided a summary table of key take-home points for clinicians and policymakers. Conclusion. Performance outcome measures are coming to rheumatology, and the most effective and meaningful measures can only be created through the close collaboration of patients, providers, measure developers, and policymakers. This study provides an overview of key issues and is intended to stimulate a productive dialogue between patients, practitioners, insurers, and government agencies regarding optimal performance outcome measure development.
引用
收藏
页码:1390 / 1401
页数:12
相关论文
共 50 条
  • [1] Defining Quality of Care in Rheumatology: The American College of Rheumatology White Paper on Quality Measurement
    Saag, Kenneth G.
    Yazdany, Jinoos
    Alexander, Christopher
    Caplan, Liron
    Coblyn, Jonathan
    Desai, Sonali Parekh
    Harrington, Timothy, Jr.
    Liu, Jigna
    McNiff, Kristen
    Newman, Eric
    Olson, Richard
    [J]. ARTHRITIS CARE & RESEARCH, 2011, 63 (01) : 2 - 9
  • [2] American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity
    Desmarais, Julianna
    Rosenbaum, James T.
    Costenbader, Karen H.
    Ginzler, Ellen M.
    Fett, Nicole
    Goodman, Susan
    O'Dell, James
    Pineau, Christian A.
    Schmajuk, Gabriela
    Werth, Victoria P.
    Link, Mark S.
    Kovacs, Richard
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (12) : 2151 - 2160
  • [3] American College of Rheumatology
    Charkin T.
    [J]. Critical Care, 3 (1):
  • [4] American College of Rheumatology
    Toby Charkin
    [J]. Arthritis Research & Therapy, 1 (1)
  • [5] American College of Rheumatology
    黄亚明
    潘现伟
    [J]. 中华内科杂志, 2012, (11) : 903 - 903
  • [6] Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: An American College of Rheumatology white paper
    Desai, Sonali P.
    Solomon, Daniel H.
    Abramson, Steven B.
    Buckley, Lenore
    Crofford, Leslie J.
    Cush, John J.
    Lovell, Daniel J.
    Saag, Kenneth G.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (08): : 1058 - 1073
  • [7] The American College of Rheumatology White Paper on Biosimilars: It Isn't All White-There Is Some Gray and Black
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70 (03) : 323 - 325
  • [8] Development of the American College of Rheumatology Toolkit for Implementation of Rheumatoid Arthritis Outcome Measures in Clinical Practice
    Nasrallah, Catherine
    Jacobsohn, Lindsay
    Schmajuk, Gabriela
    Kersey, Emma
    Young, Cammie
    Martin, Janell
    Barber, Lori
    Barton, Jennifer
    Bajaj, Puneet
    Bartels, Christie M.
    Ferguson, Sancia
    Wahl, Elizabeth
    DeQuattro, Kimberly
    Katz, Patti
    Danila, Maria I.
    Subash, Meera
    Downey, Christina
    Zell, JoAnn
    Reiter, Kimberly
    Weinstein, Elena
    Yazdany, Jinoos
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3785 - 3787
  • [9] Outcome Measures in Pediatric Rheumatology
    Sujata Sawhney
    Manjari Agarwal
    [J]. The Indian Journal of Pediatrics, 2010, 77 : 1183 - 1189
  • [10] Outcome Measures in Pediatric Rheumatology
    Sawhney, Sujata
    Agarwal, Manjari
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2010, 77 (10): : 1183 - 1189